Accellacare conducts clinical trial for Eczema sufferers
Accellacare (Formerly MeDiNova Research) is conducting clinical trials for people dealing with moderate to severe Atopic Dermatitis (Eczema).
The global clinical research network is now enrolling eligible volunteers aged between 18-65 years for a clinical trial evaluating the effectiveness of a new investigational medication for the treatment of Atopic Dermatitis.
Benefits for volunteers include:
- Helping future generations with new treatments by contributing to medical research.
- Playing an active role in your healthcare.
- Regular monitoring at trial visits, including blood pressure, ECG, blood and urine tests, height and weight, etc.
Volunteers’ GPs will be informed of their participation, and will receive the results of any investigations that may be undertaken.
With your consent, Accellacare will arrange a consultation with a doctor or nurse from your nearest Accellacare Clinic who will give you full details about the clinical trial to enable you to make an informed decision.
To find your nearest clinic please click here.
Participants can withdraw from the trial at any time, and may or may not benefit medically from taking part.